Email Us

CapitalBio Eye Segment Analysis Device

The Eye Segment Analysis Device, independently developed by CapitalBio Technology, is based on the practice of traditional Chinese medicine eye diagnosis and the theory of microcirculation of the bulbar conjunctiva of Western medicine. Combined with clinical big data using artificial intelligence (AI) and shadowless imaging optical technology, high-definition acquisition, feature extraction, and comprehensive analysis of eye images can automatically determine TCM syndromes and prone diseases, and provide personalized health management solutions.

dna sequencing kit

Features of Eye Segment Analysis Device

1. Each image capture takes only 5 seconds and is quick, easy, painless, and practical.

2. Superior quality eye picture archiving using shadowless imaging optics.

3. Automatic identification and intelligent analysis of eye features are performed using big data and machine learning to generate a customised analysis report (eye health assessment report).

Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing